Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol

被引:0
作者
Antonio Simone Laganà
Luisa Barbaro
Alfonsa Pizzo
机构
[1] University of Messina,Department of Pediatric Gynecological, Microbiological and Biomedical Sciences
[2] Family Counseling Center (Obstetrics and Gynecology Section),undefined
来源
Archives of Gynecology and Obstetrics | 2015年 / 291卷
关键词
Polycystic Ovary Syndrome; D-Chiro-Inositol; Ovarian function; Metabolic factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1181 / 1186
页数:5
相关论文
共 50 条
[31]   Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome [J].
Zacche, Martino M. ;
Caputo, Luigi ;
Filippis, Susanna ;
Zacche, Gabrio ;
Dindelli, Moreno ;
Ferrari, Augusto .
GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (08) :508-513
[32]   Assessment of ovarian stromal blood flow after metformin treatment in women with polycystic ovary syndrome [J].
Makled, Ahmed K. ;
El Sherbiny, Mohamed ;
Elkabarity, Rania .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (04) :883-891
[33]   Assessment of ovarian stromal blood flow after metformin treatment in women with polycystic ovary syndrome [J].
Ahmed K. Makled ;
Mohamed El Sherbiny ;
Rania Elkabarity .
Archives of Gynecology and Obstetrics, 2014, 289 :883-891
[34]   Frequency and risk factors for metabolic syndrome in adolescents and adults women with polycystic ovary syndrome [J].
Pedroso, Daiana Cristina Chielli ;
Melo, Anderson Sanches ;
Carolo, Adriana Lucia ;
Vieira, Carolina Sales ;
Japur de Sa Rosa e Silva, Ana Carolina ;
dos Reis, Rosana Maria .
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2010, 34 (08) :357-361
[35]   METABOLIC SYNDROME: PARTICULARITIES IN OVERWEIGHT WOMEN WITH POLYCYSTIC OVARY SYNDROME AS COMPARED WITH OBESE WOMEN WITHOUT OVARIAN DYSFUNCTION? [J].
Stoian, Dana ;
Craciunescu, Mihaela ;
Nitu, R. ;
Navolan, D. ;
Dumitru, C. ;
Craina, M. .
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (03) :690-698
[36]   Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome [J].
Cataldo, NA ;
Abbasi, F ;
McLaughlin, TL ;
Basina, M ;
Fechner, PY ;
Giudice, LC ;
Reaven, GM .
HUMAN REPRODUCTION, 2006, 21 (01) :109-120
[37]   Evaluation of Ovarian Reserve after Laparoscopic Surgery in Patients with Polycystic Ovary Syndrome [J].
Farzadi, Laya ;
Nouri, Mohammad ;
Ghojazadeh, Morteza ;
Mohiti, Mona ;
Aghadavod, Esmat .
BIOIMPACTS, 2012, 2 (03) :167-170
[38]   Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies [J].
Merviel, Philippe ;
James, Pandora ;
Bouee, Sarah ;
Le Guillou, Mathilde ;
Rince, Camille ;
Nachtergaele, Charlotte ;
Kerlan, Veronique .
REPRODUCTIVE HEALTH, 2021, 18 (01)
[39]   The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome [J].
Yin, Dongmei ;
Ruan, Xiangyan ;
Tian, Xuanxuan ;
Du, Juan ;
Zhao, Yue ;
Cui, Yamei ;
Li, Yanglu ;
Mueck, Alfred O. .
GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (04) :332-335
[40]   Clinical, hormonal and metabolic factors associated with polycystic ovary syndrome among Pakistani women [J].
Memon, Tariq Feroz ;
Meghji, Kumayl Abbas ;
Rajar, Allah Bachayo ;
Khowaja, Shumaila ;
Azam, Amjid ;
Khatoon, Sardaran .
RAWAL MEDICAL JOURNAL, 2020, 45 (04) :817-821